We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Native 64-Bit Image and Report Access Software Designed for Mac Users

By HospiMedica International staff writers
Posted on 04 Aug 2010
A new application has been designed that is intended for radiology groups who wish to provide fully featured image and report access to referring physicians with a Mac preference. More...


Intelerad Medical Systems (Denver, CO, USA), a developer of medical imaging picture archiving and communications systems (PACS) and workflow solutions, today announced the availability of InteleViewer

Specifically designed for referring physicians, InteleViewer for Mac combines the benefits of Mac computer systems, (developed by Apple, Inc.; Cupertino, CA, USA), with Intelerad's leading-edge medical imaging solutions. Mac users will experience the Mac OS X 64-bit Intel high-speed viewing, as well as full support for U.S. Food and Drug Administration (FDA)-approved medical-grade displays. Intelerad's native 64-bit InteleViewer for Mac comes with high-performance streaming of data for remote viewing and customizable layouts, which will accommodate even the most demanding specialists in orthopedics or neurosurgery. Administration tools let radiology groups define user and application preferences as well as access permissions, making InteleViewer for Mac a fully HIPAA (Health Insurance Portability and Accountability Act of 1996) -compliant application.

Easy to use from home or from the office, InteleViewer for Mac supports the entire range of Mac systems running Mac OS X Snow Leopard--from MacBook notebooks and iMac desktops to MacPro workstations--allowing radiology groups to meet the demands of modern physicians' practices.

"InteleViewer for Mac allows radiology groups to provide high-performance access to images and reports to previously overlooked Mac users,” said Chris Henri, founder and chief technology officer at Intelerad. "It is a key component of our strategy to help our customers strengthen their position in the marketplace.”

InteleViewer for Mac will be offered under an enterprise-wide licensing model for a versatile use and will be available concurrently with the upcoming IntelePACS and InteleOne releases.

Intelerad Medical Systems is a developer of medical imaging PACS and workflow solutions. IntelePACS relies on a scalable, flexible, and fault-tolerant architecture. Intelerad solutions, such as InteleOne, are known for their effectiveness, flexibility, and performance in complex, multisite environments with challenging workflows.

Related Links:

Intelerad Medical Systems



Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Surgical System
Stealth AXiS
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.